Smead US Value UCITS R GBP Acc
North AmericaPricing frequency
Daily
Dealing cut off time
14:45
Type
SICAV
Yield
–
NAV
£420.35
Income frequency
-
Ongoing charge
1.34%
Latest actual NAV date
17-11-2026
ISIN
LU0979706024
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| Cenovus Energy Inc | 7.39 |
| Merck & Co Inc | 6.92 |
| APA Corp | 6.61 |
| Macerich Co | 5.21 |
| Simon Property Group Inc | 5.18 |
| Amgen Inc | 5.09 |
| Northern Trust The US Dollar G Dis | 5.02 |
| ConocoPhillips | 4.01 |
| Target Corp | 3.98 |
| D.R. Horton Inc | 3.93 |
Investment objective
The objective of the Sub-Fund is to provide investors with long-term capital appreciation. The Sub-Fund is actively managed without reference to any benchmark. In order to achieve its investment objective, the Sub-Fund will invest in U.S. securities issued by approximately 25-30 listed companies (the number of which will be maintained in its portfolio) and will typically invest in the common stocks of large capitalization (“large-cap”) U.S. companies. The Sub-Fund considers large cap companies to be those publicly traded U.S. companies with capitalizations exceeding $5 billion. The Sub-Fund may use financial derivative instruments for hedging purposes. The Sub-Fund may not invest in total return swaps.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.